- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/00 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patent holdings for IPC class C07D 235/00
Total number of patents in this class: 121
10-year publication summary
|
3
|
8
|
4
|
6
|
6
|
11
|
12
|
1
|
7
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4648 |
6 |
| Merck Sharp & Dohme Corp. | 2190 |
5 |
| The Regents of the University of Michigan | 4697 |
5 |
| Medshine Discovery Inc. | 601 |
3 |
| Orsobio, Inc. | 13 |
3 |
| Xerox Corporation | 7002 |
2 |
| Merck Patent GmbH | 5823 |
2 |
| Board of Regents, The University of Texas System | 5803 |
2 |
| The Board of Trustees of the University of Illinois | 2694 |
2 |
| Array BioPharma Inc. | 502 |
2 |
| The Broad Institute, Inc. | 1818 |
2 |
| Children's Medical Center Corporation | 1864 |
2 |
| Regents of the University of Minnesota | 2694 |
2 |
| Sumitomo Bakelite Co., Ltd. | 1499 |
2 |
| University of Maryland, Baltimore | 1020 |
2 |
| The University of Montana | 101 |
2 |
| Kyowa Kirin Co., Ltd. | 367 |
2 |
| Aryl Therapeutics, Inc. | 2 |
2 |
| Glaxo Group Limited | 4068 |
1 |
| Novartis AG | 10850 |
1 |
| Other owners | 71 |